STOCK TITAN

Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) will host a booth at Africa Health/Medlab Africa in Johannesburg, South Africa from October 26-28, 2022. This significant event brings together healthcare professionals from the South African Development Community and beyond, showcasing the latest in medical technology and services. Co-Diagnostics will present their innovative CoPrimer™ PCR technology and infectious disease products, alongside the upcoming Co-Dx PCR Home testing platform. Attendees can find registration details here.

Positive
  • None.
Negative
  • None.

SALT LAKE CITY, Oct. 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week at Africa Health/Medlab Africa in Johannesburg, South Africa on October 26-28, 2022.

The conference is the largest gathering of healthcare companies, technology, products and services in the sub-Saharan region, catering to an audience of professionals from the South African Development Community region and around the world, including distributors, government representatives, laboratory executives, and purchasing/procurement managers, who attend to meet with world-class suppliers and manufacturers.

The Company's booth will showcase Co-Diagnostics' state-of-the-art CoPrimer™ PCR technology and infectious disease products to conference attendees, along with its upcoming Co-Dx PCR Home testing platform.

Additional details, including registration information, can be found here.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medlab-africa-on-oct-26-28-in-south-africa-301659643.html

SOURCE Co-Diagnostics

FAQ

What event is Co-Diagnostics, Inc. attending in October 2022?

Co-Diagnostics, Inc. is attending Africa Health/Medlab Africa in Johannesburg, South Africa, from October 26-28, 2022.

What will Co-Diagnostics showcase at the Medlab Africa conference?

Co-Diagnostics will showcase their CoPrimer™ PCR technology, infectious disease products, and the upcoming Co-Dx PCR Home testing platform.

Why is the Africa Health/Medlab Africa conference significant?

It is the largest gathering of healthcare companies and professionals in the sub-Saharan region, attracting distributors, government representatives, and laboratory executives.

How can attendees register for the Africa Health/Medlab Africa event?

Registration information can be found on the official event website here.

What is the stock symbol for Co-Diagnostics, Inc.?

The stock symbol for Co-Diagnostics, Inc. is CODX.

Co-Diagnostics, Inc.

NASDAQ:CODX

CODX Rankings

CODX Latest News

CODX Stock Data

26.50M
29.79M
6.7%
13.93%
0.73%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY